MedPath

levocetirizine dihydrochloride

These highlights do not include all the information needed to use LEVOCETIRIZINE DIHYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for LEVOCETIRIZINE DIHYDROCHLORIDE TABLETS. Initial U.S. Approval: 1995

Approved
Approval ID

c40c1bb4-25ce-90cb-b8dd-6a4c54cddd4a

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 6, 2018

Manufacturers
FDA

Dr.Reddy's laboratories Ltd.

DUNS: 650562841

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

levocetirizine dihydrochloride

PRODUCT DETAILS

NDC Product Code55111-282
Application NumberANDA090392
Marketing CategoryC73584
Route of AdministrationORAL
Effective DateDecember 6, 2018
Generic Namelevocetirizine dihydrochloride

INGREDIENTS (8)

levocetirizine dihydrochlorideActive
Quantity: 5 mg in 1 1
Code: SOD6A38AGA
Classification: ACTIB
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
HYPROMELLOSESInactive
Code: 3NXW29V3WO
Classification: IACT
POLYETHYLENE GLYCOL, UNSPECIFIEDInactive
Code: 3WJQ0SDW1A
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

levocetirizine dihydrochloride - FDA Drug Approval Details